GetPortalImpactFactorByIdResp(projectId=1, id=4b7a13250, cover=https://img.medsci.cn/20231103/1698991521310_1614372.jpg, fullname=Therapeutic Advances in Musculoskeletal Disease, abbr=THER ADV MUSCULOSKEL, pyear=2009, frequence=Monthly, articleNumbers=479, citedSelf2015=1.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均6月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1759-720X, greenSci=https://www.greensci.net/search?kw=1759-720X, scijournal=https://www.scijournal.org/impact-factor-of-THER-ADV-MUSCULOSKEL.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.663, medsciHotlight=2.042, medsciHotlight5year=0.882789, citescore=6.8, hIndex=35, impactFactor=4.2, orgnization=SAGE Publications Inc., orgnizationUrl=https://uk.sagepub.com/en-gb/asi/home, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=Clarivate Analytics: Current Contents - Clinical Medicine Clarivate Analytics: Science Citation Index Expanded (SCIE),Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) Scopus, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://journals.sagepub.com/home/TAB, websiteHits=396, guideForAuthor=https://journals.sagepub.com/author-instructions/TAB, guideForAuthorHits=91, submitWebsite=https://mc.manuscriptcentral.com/tamd, submitWebsiteHits=102, content=<p>该刊是一份经过同行评审的开放获取期刊，重点关注风湿病学、骨质疏松症及相关学科领域的开拓性工作和创新性研究。</p>, totalCites=2015, brief=THER ADV MUSCULOSKEL杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=风湿病学" >风湿病学</a></strong>”子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=THER ADV MUSCULOSKEL在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=4b7a13250'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.04), GetImpactFactorCiteScoreListResponse(year=2019, citescore=8.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=5.5), GetImpactFactorCiteScoreListResponse(year=2023, citescore=6.8)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=1.282), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.723), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.829), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.594), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.663)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Orthopedics and Sports Medicine , rank=9/244), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Rheumatology , rank=10/53)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1759-720X[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE[ta], article_number=93, article_number_cn=12, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)